Ebixa
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Ebixa, covering 2022-01-05 to 2026-07-08. Get the full timeline:
Most recent: EMA Authorised: Ebixa (memantine hydrochloride) — H. Lundbeck A/S
2 regulatory and trial events tracked for Ebixa, covering 2022-01-05 to 2026-07-08. Get the full timeline:
Most recent: EMA Authorised: Ebixa (memantine hydrochloride) — H. Lundbeck A/S